{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:30:27Z","timestamp":1770823827733,"version":"3.50.1"},"reference-count":36,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,4,1]]},"abstract":"<jats:p>Diffuse large B-cell lymphoma (DLBCL), a histologically well-defined subset of non-Hodgkin lymphoma, is clinically and genetically heterogenous. By G-banding, most cases showed complex hyperdiploid karyotypes and diverse cytogenetic abnormalities that included recurring and nonrecurring translocations, deletions, duplications, and marker chromosomes. While G-banding provided valuable leads to identification of specific rearrangements that enabled gene discovery and clinical correlations, many aberrations remained uncharacterized because of their complexity. The molecular cytogenetic technique spectral karyotyping (SKY), on the other hand, enables complete characterization of all aberrations in a tumor cell karyotype and, hence, precise quantitation of chromosome instability. We report here, for the first time, SKY analysis of a panel of 46 DLBCL cases previously analyzed by G-banding, ascertained at the Memorial Sloan-Kettering Cancer Center. This analysis provided a cytogenetic profile of DLBCL that was characterized by a higher level of instability, qualitatively as well as quantitatively, compared with G-banding. Thus, 551 breakpoints were detected by SKY, in contrast to the 295 by G-banding. Several new recurring breakpoints, translocations, and regions of gain and loss were identified, which included 13 breakpoints not previously identified by G-banding, 10 breakpoints that were underrepresented by G-banding, and 4 previously unrecognized translocations: der(14)t(3;14)(q21;q32), t(1;13)(p32;q14), t(1;7)(q21;q22), and der(6)t(6;8)(q11;q11). We identified new clinical associations involving recurring breakpoints detected by SKY. These studies emphasize the value of SKY analysis for redefinition of chromosomal instability in DLBCL to enhance gene discovery as well as clinical correlation analysis.<\/jats:p>","DOI":"10.1182\/blood.v99.7.2554","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T18:33:52Z","timestamp":1034361232000},"page":"2554-2561","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":36,"title":["Spectral karyotyping identifies new rearrangements, translocations, and clinical associations in diffuse large B-cell lymphoma"],"prefix":"10.1182","volume":"99","author":[{"given":"Gouri","family":"Nanjangud","sequence":"first","affiliation":[{"name":"From the Cell Biology Program and the Departments of Medicine, Pathology, and Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pulivarthi H.","family":"Rao","sequence":"additional","affiliation":[{"name":"From the Cell Biology Program and the Departments of Medicine, Pathology, and Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhijith","family":"Hegde","sequence":"additional","affiliation":[{"name":"From the Cell Biology Program and the Departments of Medicine, Pathology, and Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Teruya-Feldstein","sequence":"additional","affiliation":[{"name":"From the Cell Biology Program and the Departments of Medicine, Pathology, and Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard","family":"Donnelly","sequence":"additional","affiliation":[{"name":"From the Cell Biology Program and the Departments of Medicine, Pathology, and Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Qin","sequence":"additional","affiliation":[{"name":"From the Cell Biology Program and the Departments of Medicine, Pathology, and Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh C.","family":"Jhanwar","sequence":"additional","affiliation":[{"name":"From the Cell Biology Program and the Departments of Medicine, Pathology, and Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew D.","family":"Zelenetz","sequence":"additional","affiliation":[{"name":"From the Cell Biology Program and the Departments of Medicine, Pathology, and Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. S. K.","family":"Chaganti","sequence":"additional","affiliation":[{"name":"From the Cell Biology Program and the Departments of Medicine, Pathology, and Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2020021222173128900_B1","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0037-1963(00)90019-2","article-title":"Recurring chromosomal abnormalities in non-Hodgkin's lymphoma: biologic and clinical significance.","volume":"37","author":"Chaganti","year":"2000","journal-title":"Semin Hematol."},{"key":"2020021222173128900_B2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature."},{"key":"2020021222173128900_B3","doi-asserted-by":"crossref","first-page":"10209","DOI":"10.1073\/pnas.180316097","article-title":"Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas.","volume":"97","author":"Lossos","year":"2000","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021222173128900_B4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/(SICI)1098-2264(199906)25:2<123::AID-GCC8>3.0.CO;2-4","article-title":"Cytogenetic analysis of 363 consecutively ascertained diffuse large B-cell lymphomas.","volume":"25","author":"Cigudosa","year":"1999","journal-title":"Genes Chromosomes Cancer."},{"key":"2020021222173128900_B5","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1126\/science.273.5274.494","article-title":"Multicolor spectral karyotyping of human chromosomes.","volume":"273","author":"Schrock","year":"1996","journal-title":"Science."},{"key":"2020021222173128900_B6","first-page":"1743","article-title":"Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma.","volume":"92","author":"Rao","year":"1998","journal-title":"Blood."},{"key":"2020021222173128900_B7","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.1182\/blood.V92.11.4269","article-title":"Identification of new nonrandom translocations in multiple myeloma with multicolor spectral karyotyping.","volume":"92","author":"Sawyer","year":"1998","journal-title":"Blood."},{"key":"2020021222173128900_B8","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood.V93.6.2038.406a32_2038_2042","article-title":"Spectral karyotype analysis of T-cell acute leukemia.","volume":"93","author":"Rowley","year":"1999","journal-title":"Blood."},{"key":"2020021222173128900_B9","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/sj.leu.2401775","article-title":"Comparison of spectral karyotyping and conventional cytogenetics in 39 patients with acute myeloid leukemia and myelodysplastic syndrome.","volume":"14","author":"Mohr","year":"2000","journal-title":"Leukemia."},{"key":"2020021222173128900_B10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0165-4608(99)00223-X","article-title":"Acute leukemia cytogenetics: an evaluation of combining G-band karyotyping with multi-color spectral karyotyping.","volume":"124","author":"Kerndrup","year":"2001","journal-title":"Cancer Genet Cytogenet."},{"key":"2020021222173128900_B11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/gcc.1104","article-title":"Reassessment of childhood B-lineage lymphoblastic leukemia karyotypes using spectral analysis.","volume":"30","author":"Elghezal","year":"2001","journal-title":"Genes Chromosomes Cancer."},{"key":"2020021222173128900_B12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/gcc.2870030304","article-title":"Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment.","volume":"3","author":"Offit","year":"1991","journal-title":"Genes Chromosomes Cancer."},{"key":"2020021222173128900_B13","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1182\/blood.V77.7.1508.1508","article-title":"Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: clinical correlations.","volume":"77","author":"Offit","year":"1991","journal-title":"Blood."},{"key":"2020021222173128900_B14","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1023\/A:1008375931236","article-title":"The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997.","volume":"10","author":"Harris","year":"1999","journal-title":"Ann Oncol."},{"key":"2020021222173128900_B15","volume-title":"ISCN: An International System for Human Cytogenetic Nomenclature.","author":"Mitleman","year":"1995"},{"key":"2020021222173128900_B16","doi-asserted-by":"crossref","first-page":"7686","DOI":"10.1038\/sj.onc.1204989","article-title":"Deregualtion of FCGR2B expression by 1q21 rearrangements in follicular lymphomas.","volume":"20","author":"Chen","year":"2001","journal-title":"Oncogene."},{"key":"2020021222173128900_B17","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin's lymphoma.","volume":"329","author":"The International Non-Hodgkin's Lymphoma Prognostic Factors Project","year":"1993","journal-title":"N Engl J Med."},{"key":"2020021222173128900_B18","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1182\/blood.V66.6.1414.1414","article-title":"There are differences in cytogenetic abnormalities among histologic subtypes of the non-Hodgkin's lymphomas.","volume":"66","author":"Levine","year":"1985","journal-title":"Blood."},{"key":"2020021222173128900_B19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2141.1990.tb07877.x","article-title":"Cytogenetic analysis of 147 cases of non-Hodgkin's lymphoma: non-random chromosomal abnormalities and histological correlations.","volume":"76","author":"Juneja","year":"1990","journal-title":"Br J Haematol."},{"key":"2020021222173128900_B20","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1182\/blood.V75.9.1841.1841","article-title":"Chromosomal abnormalities in untreated patients with non-Hodgkin's lymphoma: associations with histology, clinical characteristics, and treatment outcome. The Nebraska Lymphoma Study Group.","volume":"75","author":"Schouten","year":"1990","journal-title":"Blood."},{"key":"2020021222173128900_B21","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1182\/blood.V86.10.3905.bloodjournal86103905","article-title":"Cytogenetic evolution patterns in non-Hodgkin's lymphoma.","volume":"86","author":"Johansson","year":"1995","journal-title":"Blood."},{"key":"2020021222173128900_B22","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1182\/blood.V92.1.234.413k22_234_240","article-title":"Chromosomal and gene amplification in diffuse large B-cell lymphoma.","volume":"92","author":"Rao","year":"1998","journal-title":"Blood."},{"key":"2020021222173128900_B23","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1182\/blood.V87.12.5269.bloodjournal87125269","article-title":"DNA copy number changes in diffuse large B-cell lymphoma\u2014comparative genomic hybridization study.","volume":"87","author":"Monni","year":"1996","journal-title":"Blood."},{"key":"2020021222173128900_B24","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1182\/blood.V90.3.1168","article-title":"BCL2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma.","volume":"90","author":"Monni","year":"1997","journal-title":"Blood."},{"key":"2020021222173128900_B25","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/gcc.10016","article-title":"Similar patterns of genomic alterations characterize primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma.","volume":"33","author":"Palanisamy","year":"2002","journal-title":"Genes Chromosomes Cancer."},{"key":"2020021222173128900_B26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/oxfordjournals.annonc.a058361","article-title":"The clinical relevance of t(14;18)\/BCL-2 rearrangement and DEL 6q in diffuse large cell lymphoma and immunoblastic lymphoma.","volume":"4","author":"Romaguera","year":"1993","journal-title":"Ann Oncol."},{"key":"2020021222173128900_B27","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0889-8588(05)70466-4","article-title":"Pathologic prognostic factors in diffuse aggressive non-Hodgkin's lymphoma.","volume":"11","author":"Gascoyne","year":"1997","journal-title":"Hematol Oncol Clin North Am."},{"key":"2020021222173128900_B28","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1182\/blood.V83.9.2423.2423","article-title":"LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients.","volume":"83","author":"Bastard","year":"1994","journal-title":"Blood."},{"key":"2020021222173128900_B29","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1200\/JCO.1994.12.1.149","article-title":"Clinical significance of bcl-2-MBR gene rearrangement and protein expression in diffuse large-cell non-Hodgkin's lymphoma: an analysis of 83 cases.","volume":"12","author":"Tang","year":"1994","journal-title":"J Clin Oncol."},{"key":"2020021222173128900_B30","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1182\/blood.V92.9.3152","article-title":"Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma.","volume":"92","author":"Kramer","year":"1998","journal-title":"Blood."},{"key":"2020021222173128900_B31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1023\/A:1008201729596","article-title":"Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: clinical relevance in 71 patients.","volume":"9","author":"Vitolo","year":"1998","journal-title":"Ann Oncol."},{"key":"2020021222173128900_B32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.7326\/0003-4819-108-1-14","article-title":"Cytogenetic abnormalities predict clinical outcome in non-Hodgkin lymphoma.","volume":"108","author":"Levine","year":"1988","journal-title":"Ann Intern Med."},{"key":"2020021222173128900_B33","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1056\/NEJM198904203201605","article-title":"bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma.","volume":"320","author":"Yunis","year":"1989","journal-title":"N Engl J Med."},{"key":"2020021222173128900_B34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0002-9343(89)80692-8","article-title":"Refractoriness to chemotherapy and poor survival related to abnormalities of chromosomes 17 and 7 in lymphoma.","volume":"87","author":"Cabanillas","year":"1989","journal-title":"Am J Med."},{"key":"2020021222173128900_B35","first-page":"3114","article-title":"Clinicopathogenetic significance of chromosomal abnormalities in patients with blastic peripheral B-cell lymphoma. Kiel-Wien-Lymphoma Study Group.","volume":"94","author":"Schlegelberger","year":"1999","journal-title":"Blood."},{"key":"2020021222173128900_B36","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1182\/blood.V85.1.203.bloodjournal851203","article-title":"Sequential analysis of 43 patients with non-Hodgkin's lymphoma: clinical correlations with cytogenetic, histologic, immunophenotyping, and molecular studies.","volume":"85","author":"Whang-Peng","year":"1995","journal-title":"Blood."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/7\/2554\/1682263\/2554.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/7\/2554\/1682263\/2554.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T03:18:30Z","timestamp":1581563910000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/99\/7\/2554\/106772\/Spectral-karyotyping-identifies-new-rearrangements"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4,1]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2002,4,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v99.7.2554","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2002,4,1]]}}}